Clinical Trial Update: Efficacy and Safety of Conventional Symptomatic Drugs Combined with Lencanizumab in the Treatment of Early Alzheimer's Disease: a Multicenter, Prospective, Observational Study

View source ↗

Summary

A multicenter, prospective observational study evaluating the safety and efficacy of combining conventional symptomatic Alzheimer's therapies with Lencanizumab …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment Due to Alzheimer Disease

Drugs mentioned

• Lencanizumab

Snippet

Sponsor: First Hospital of China Medical University | Conditions: Alzheimer's Disease, MCI-AD, Early Stage Alzheimer's Disease | Status: NOT_YET_RECRUITING